Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.
The predictive value of serum uric acid (SUA) for adverse cardiovascular events among obese and overweight patients is not known, but potentially important because of the relation between hyperuricaemia and obesity.The relationship between SUA and risk of cardiovascular adverse outcomes (nonfatal my...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3606441?pdf=render |
| _version_ | 1811320783800107008 |
|---|---|
| author | Helle Skak-Nielsen Christian Torp-Pedersen Nick Finer Ian D Caterson Luc Van Gaal W Philip T James Aldo Pietro Maggioni Arya M Sharma Walmir Coutinho Charlotte Andersson |
| author_facet | Helle Skak-Nielsen Christian Torp-Pedersen Nick Finer Ian D Caterson Luc Van Gaal W Philip T James Aldo Pietro Maggioni Arya M Sharma Walmir Coutinho Charlotte Andersson |
| author_sort | Helle Skak-Nielsen |
| collection | DOAJ |
| description | The predictive value of serum uric acid (SUA) for adverse cardiovascular events among obese and overweight patients is not known, but potentially important because of the relation between hyperuricaemia and obesity.The relationship between SUA and risk of cardiovascular adverse outcomes (nonfatal myocardial infarction, nonfatal stroke, resuscitated cardiac arrest or cardiovascular death) and all-cause mortality, respectively, was evaluated in a post-hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Participants enrolled in SCOUT were obese or overweight with pre-existing diabetes and/or cardiovascular disease (CVD). Cox models were used to assess the role of SUA as an independent risk factor.9742 subjects were included in the study; 83.6% had diabetes, and 75.1% had CVD. During an average follow-up time of 4.2 years, 1043 subjects had a primary outcome (myocardial infarction, resuscitated cardiac arrest, stroke, or cardiovascular death), and 816 died. In a univariate Cox model, the highest SUA quartile was associated with an increased risk of cardiovascular adverse outcomes compared with the lowest SUA quartile in women (hazard ratio [HR]: 1.59; 95% confidence interval [CI]: 1.20-2.10). In multivariate analyses, adjusting for known cardiovascular risk factors the increased risk for the highest SUA quartile was no longer statistically significant among women (HR: 0.99; 95% CI: 0.72-1.36) nor was it among men. Analyses of all-cause mortality found an interaction between sex and SUA. In a multivariate Cox model including women only, the highest SUA quartile was associated with an increased risk in all-cause mortality compared to the lowest SUA quartile (HR: 1.51; 95% CI: 1.08-2.12). No relationship was observed in men (HR: 1.06; 95% CI: 0.82-1.36).SUA was not an independent predictor of cardiovascular disease and death in these high-risk overweight/obese people. However, our results suggested that SUA was an independent predictor of all-cause mortality in women. |
| first_indexed | 2024-04-13T13:05:31Z |
| format | Article |
| id | doaj.art-b2c34c6884514fe3b42228532ead0e78 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T13:05:31Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-b2c34c6884514fe3b42228532ead0e782022-12-22T02:45:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e5912110.1371/journal.pone.0059121Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.Helle Skak-NielsenChristian Torp-PedersenNick FinerIan D CatersonLuc Van GaalW Philip T JamesAldo Pietro MaggioniArya M SharmaWalmir CoutinhoCharlotte AnderssonThe predictive value of serum uric acid (SUA) for adverse cardiovascular events among obese and overweight patients is not known, but potentially important because of the relation between hyperuricaemia and obesity.The relationship between SUA and risk of cardiovascular adverse outcomes (nonfatal myocardial infarction, nonfatal stroke, resuscitated cardiac arrest or cardiovascular death) and all-cause mortality, respectively, was evaluated in a post-hoc analysis of the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Participants enrolled in SCOUT were obese or overweight with pre-existing diabetes and/or cardiovascular disease (CVD). Cox models were used to assess the role of SUA as an independent risk factor.9742 subjects were included in the study; 83.6% had diabetes, and 75.1% had CVD. During an average follow-up time of 4.2 years, 1043 subjects had a primary outcome (myocardial infarction, resuscitated cardiac arrest, stroke, or cardiovascular death), and 816 died. In a univariate Cox model, the highest SUA quartile was associated with an increased risk of cardiovascular adverse outcomes compared with the lowest SUA quartile in women (hazard ratio [HR]: 1.59; 95% confidence interval [CI]: 1.20-2.10). In multivariate analyses, adjusting for known cardiovascular risk factors the increased risk for the highest SUA quartile was no longer statistically significant among women (HR: 0.99; 95% CI: 0.72-1.36) nor was it among men. Analyses of all-cause mortality found an interaction between sex and SUA. In a multivariate Cox model including women only, the highest SUA quartile was associated with an increased risk in all-cause mortality compared to the lowest SUA quartile (HR: 1.51; 95% CI: 1.08-2.12). No relationship was observed in men (HR: 1.06; 95% CI: 0.82-1.36).SUA was not an independent predictor of cardiovascular disease and death in these high-risk overweight/obese people. However, our results suggested that SUA was an independent predictor of all-cause mortality in women.http://europepmc.org/articles/PMC3606441?pdf=render |
| spellingShingle | Helle Skak-Nielsen Christian Torp-Pedersen Nick Finer Ian D Caterson Luc Van Gaal W Philip T James Aldo Pietro Maggioni Arya M Sharma Walmir Coutinho Charlotte Andersson Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS ONE |
| title | Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. |
| title_full | Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. |
| title_fullStr | Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. |
| title_full_unstemmed | Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. |
| title_short | Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. |
| title_sort | uric acid as a risk factor for cardiovascular disease and mortality in overweight obese individuals |
| url | http://europepmc.org/articles/PMC3606441?pdf=render |
| work_keys_str_mv | AT helleskaknielsen uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT christiantorppedersen uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT nickfiner uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT iandcaterson uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT lucvangaal uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT wphiliptjames uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT aldopietromaggioni uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT aryamsharma uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT walmircoutinho uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals AT charlotteandersson uricacidasariskfactorforcardiovasculardiseaseandmortalityinoverweightobeseindividuals |